Breast Video Channel
Explore the latest insights and summaries from experts in Breast.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 1,501 views
- December 22, 2024
- 6
Oncology 2024 Year in Review
Year in Review 2024: Top Metastatic Breast Cancer Trials
FEATURING
Virginia Kaklamani
- 1,240 views
- December 24, 2024
- 7
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 4,887 views
- June 7, 2024
- 33
Sara Tolaney
SABCS 2024 Noteworthy Abstracts in Early Breast Cancer
FEATURING
Hope Rugo
- 966 views
- November 19, 2024
- 10
Oncology 2024 Year in Review
Year in Review 2024 - Transformative FDA Approvals in Precision Oncology Across Various Cancer Types
FEATURING
Vivek Subbiah
- 1,338 views
- December 17, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-Breast12, KEYNOTE-522, CAPItello-290 & ICARUS-Breast01
FEATURING
Paolo Tarantino
- 1,371 views
- September 24, 2024
- 6
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 555 views
- December 22, 2024
- 10
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EMBER-3
FEATURING
Adam Brufsky
- 545 views
- December 18, 2024
- 8
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx
FEATURING
Virginia Kaklamani
- 402 views
- January 2, 2025
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA
FEATURING
Sara Tolaney,
Hope Rugo
- 470 views
- December 22, 2024
- 6
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PADMA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 339 views
- December 22, 2024
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Impact of Anthracyclines in High Genomic Risk Node-Negative HR+/HER2- eBC
FEATURING
Nan Chen
- 302 views
- January 2, 2025
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, DESTINY-BREAST12, and CAPItello-290
FEATURING
Virginia Kaklamani
- 674 views
- September 23, 2024
- 7
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
Evolution of Treatment Algorithms for HER2+ mBC
FEATURING
Mridula George
- 553 views
- September 26, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: eBC Panel Discussion on Key Studies - KEYNOTE-522, I-SPY 2.2, and NATALEE
FEATURING
Sara Tolaney,
Hope Rugo
- 648 views
- October 4, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Breast12, CAPItello-290, and ICARUS-BREAST01
FEATURING
Sara Tolaney,
Hope Rugo
- 579 views
- October 4, 2024
- 7
Kathryn Post
Perspectives on the Effects of Time Toxicity in Breast Cancer Treatment
FEATURING
Jennifer Hutchinson
- 716 views
- October 3, 2024
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer
FEATURING
Laszlo Tabar
- 268 views
- December 17, 2024
- 9
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients With Bone Metastases
FEATURING
Robbe Van den Begin
- 660 views
- September 26, 2024
- 8
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 1L Setting
FEATURING
Ruth O'Regan
- 1,391 views
- March 12, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Tailoring Therapy in TNBC and Beyond
FEATURING
Lisa Carey
- 378 views
- October 8, 2024
- 5
Sara Tolaney
ESMO 2024 Noteworthy Abstracts in Breast Cancer
FEATURING
Hope Rugo
- 603 views
- August 30, 2024
- 9
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer
FEATURING
Christos Vaklavas
- 255 views
- December 17, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Systemic Treatment for ILCs in Breast Cancer
FEATURING
Jens Huober
- 367 views
- October 17, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Innovative Immunotherapy Approaches in Breast Cancer
FEATURING
Heather McArthur
- 182 views
- December 19, 2024
- 7
University of Illinois Cancer Center
Optimizing Treatment Sequencing for Metastatic TNBC
FEATURING
V.K. Gadi
- 208 views
- December 6, 2024
- 3
Insights from 2023 SABCS
SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+ mBC?"
FEATURING
Sara Tolaney,
Hope Rugo
- 3,007 views
- December 21, 2023
- 17
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Panel Discussion: "Key Updates in Breast Cancer"
FEATURING
Sara Tolaney,
Hope Rugo
- 973 views
- June 10, 2024
- 6
University of Illinois Cancer Center
HR+/HER2- Early Breast Cancer: Risk Assessment and Treatment Updates
FEATURING
V.K. Gadi
- 234 views
- November 19, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Immunotherapy in eTNBC - Is It the End of the Beginning?
FEATURING
Giampaolo Bianchini
- 171 views
- January 17, 2025
- 3
Dana-Farber Cancer Institute
Year in Review: Breast Cancer
FEATURING
Paolo Tarantino
- 2,425 views
- February 1, 2024
- 18
Daniele Generali
Navigating Treatment Sequencing Post T-DXd Progression for HER2+ mBC
- 287 views
- November 15, 2024
Icahn School of Medicine at Mount Sinai
De-Escalation of Systemic Therapy For Early Stage Breast Cancer
FEATURING
Amy Tiersten
- 187 views
- November 19, 2024
- 4
Margaret Gatti-Mays
Immunotherapy for TNBC: Remaining Questions and New Directions
- 175 views
- November 27, 2024
- 2
Total Health
Neoadjuvant Chemo for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 997 views
- March 2, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Immunotherapy Strategies in ER+ Breast Cancer
FEATURING
Cesar Santa-Maria
- 125 views
- January 21, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Effectiveness of Post-T-DXd Treatments in HER2+ mBC - EN-SEMBLE Study
FEATURING
Kazuki Nozawa
- 117 views
- December 20, 2024
- 4
Total Health
Overview of Early Stage HR+/HER2- BC Updates
FEATURING
Sonia Benn
- 129 views
- November 5, 2024
- 1
Yale Cancer Center
Individualizing Adjuvant Therapy for HR+/HER2- eBC
FEATURING
Anca Bulgaru
- 146 views
- November 25, 2024
- 2
ecancer
SABCS 2024 Insights: Association Between Risk-Reducing Surgeries and Survival in Young BRCA Carriers With Breast Cancer
FEATURING
Matteo Lambertini
- 108 views
- January 17, 2025
- 1
Andrew Redfern
Something Old, New, or Borrowed: Optimizing 2L Therapy in HR+ HER2- mBC Post-CDK4/6 Inhibition
- 119 views
- November 15, 2024
- 3
Dana-Farber Cancer Institute
Management of HER2+ mBC: Treatment Decisions After T-DXd Progression
FEATURING
Guilherme Nader-Marta
- 87 views
- January 18, 2025
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNOTE-756 & BEGONIA"
FEATURING
Paolo Tarantino
- 2,112 views
- November 3, 2023
- 12
2024 ASCO® Annual Meeting Insights Hub
Management of Higher Risk eBC Including BRCAm, HER2- Subtypes
FEATURING
Milana Dolezal
- 395 views
- July 2, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Residual Cancer Burden & Adjuvant Capecitabine in Early TNBC With Non-pCR
FEATURING
Sung-Bae Kim
- 85 views
- November 15, 2024
- 1
University of Illinois Cancer Center
Recent Updates in Early-Stage Breast Cancer: Treatment Options and Key Trial Insights
FEATURING
Abiola Ibraheem
- 82 views
- December 18, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Treatment and Outcomes in Select Subpopulations With Breast Cancer
FEATURING
Lisa Carey
- 377 views
- June 18, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Hypo vs. Normofractionated RT in eBC - 5-Year Results of HypoG-01
FEATURING
Sofia Rivera
- 170 views
- September 20, 2024
- 1
UNC Lineberger Comprehensive Cancer Center
Updates in the Surgical Management for Breast Cancer
FEATURING
Kristalyn Gallagher
- 240 views
- July 19, 2024
- 5
Insights from 2023 SABCS
SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HER2CLIMB-02"
FEATURING
Paolo Tarantino
- 1,074 views
- December 18, 2023
- 7
UChicago Medicine
2024 (Neo)Adjuvant Systemic Therapy Updates for HR+ BC
FEATURING
Gini Fleming
- 571 views
- March 1, 2024
- 7
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"
FEATURING
Sara Tolaney,
Hope Rugo
- 1,473 views
- November 3, 2023
- 9
Insights from 2023 SABCS
Year in Review: Metastatic Breast Cancer
FEATURING
Mariana Chavez Mac Gregor
- 962 views
- January 3, 2024
- 10
Yale Cancer Center
Breast Medical Oncology: A Multidisciplinary and Personalized Cancer Care Approach
FEATURING
Sarah Schellhorn Mougalian
- 64 views
- November 25, 2024
University of Illinois Cancer Center
Key Updates in Metastatic HER2+++ Breast Cancer
FEATURING
V.K. Gadi
- 44 views
- December 6, 2024
- 1
Insights from 2023 SABCS
SABCS 2023 Insights: "NRG Oncology/NSABP B-51/RTOG 1304 Trial - Loco-Regional Irradiation in Patients With Biopsy-Proven Axillary Node Involvement at Presentation Who Become Pathologically Node- After Neoadjuvant Chemo"
FEATURING
Terry Mamounas
- 1,106 views
- December 13, 2023
- 8
Bruce Haffty
Omitting PMRT or Nodal RT in Breast Cancer After Node Conversion: NRG B51 Insights
- 104 views
- August 9, 2024
- 3
Keck School of Medicine of USC
Breast Cancer Oligometastases and Beyond
FEATURING
Steven Chmura
- 547 views
- February 22, 2024
- 2
Grace Choong
Resistance Mutations in HR+ mBC After 1L ET + CDK4/6i: Next Lines and Treatment Sequencing
- 764 views
- January 3, 2024
- 8
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
De-Escalation of Radiation in Breast Cancer: Finding the Optimal Balance
FEATURING
Bruce Haffty
- 44 views
- November 19, 2024
- 2
Total Health
Overview of Early Stage HER2+ BC Updates
FEATURING
Sonia Benn
- 59 views
- November 5, 2024
- 1
Integrity CE
SABCS 2023 Summary: "monarchE & NATALEE Trials - Adjuvant Treatment in Patients With HR+/HER2- eBC"
FEATURING
Aditya Bardia
- 415 views
- January 26, 2024
- 3
Dana-Farber Cancer Institute
Standard Treatments for HR+/HER2- mBC in 2023
FEATURING
Sarah Sammons
- 919 views
- November 14, 2023
- 7
Yale Cancer Center
Breast Reconstruction: Options and Approaches
FEATURING
Paris Butler
- 53 views
- November 25, 2024
Insights from 2023 SABCS
SABCS 2023 Insights: "Optimizing Adjuvant Endocrine Therapy for Premenopausal Women"
FEATURING
Vered Stearns
- 469 views
- March 2, 2024
- 2
Cesar Santa-Maria
Validating pCR as an Endpoint for eBC Therapy Approval
- 104 views
- August 27, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: A Registry-Based Study of pCR & Survival After Neoadjuvant Chemo in Stage I TNBC
FEATURING
Manon De Graaf
- 54 views
- October 1, 2024
- 1
COR2ED The Heart of Medical Education
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, DESTINY-Breast12, and NATALEE
FEATURING
François-Clément Bidard
- 56 views
- October 25, 2024
Cedars Sinai
2024 Updates in eBC Treatment for Postmenopausal HR+/HER2- Patients
FEATURING
Yuan Yuan
- 255 views
- April 18, 2024
- 2
Insights from 2023 SABCS
SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & HER2CLIMB-02 Trials"
FEATURING
Sara Tolaney,
Hope Rugo
- 420 views
- January 22, 2024
- 2
Insights from 2023 SABCS
SABCS 2023 Summary: "Is There a Role for IO in Early Stage High Risk ER+ BC?"
FEATURING
Sara Tolaney,
Hope Rugo
- 570 views
- December 21, 2023
- 4
Insights from 2023 SABCS
SABCS 2023 Summary: "Is There a Role for Purely Adjuvant IO in Early Stage TNBC?"
FEATURING
Sara Tolaney,
Hope Rugo
- 434 views
- December 21, 2023
- 6
ecancer
Best of ASCO®️ 2024: Adjuvant and Metastatic Indications of HR+ BC
FEATURING
Aurelio Castrellon
- 120 views
- August 2, 2024
- 1
Sheldon Feldman
New Approaches to Decrease the Risk of Breast Cancer-Related Lymphedema
- 75 views
- August 27, 2024
- 1
Total Health
Neoadjuvant ET for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 205 views
- March 2, 2024
- 3
Dana-Farber Cancer Institute
Older Adults With Breast Cancer: Research Updates
FEATURING
Rachel Freedman
- 266 views
- March 1, 2024
- 3
Yale Cancer Center
Axillary Management: To Dissect or Not to Dissect
FEATURING
Ellie Proussaloglou
- 44 views
- October 21, 2024
OncoAlert
HER2+ mBC: Year-in-Review Including DESTINY Breast-03 & HER2CLIMB-02 Trials
FEATURING
Stephanie Graff
- 311 views
- February 15, 2024
- 2
Total Health
Current Adjuvant Treatment in HR+ BC
FEATURING
Gregory Vidal
- 160 views
- March 12, 2024
- 2
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 104 views
- July 2, 2024
- 1
Total Health
Advances in Early Stage TNBC: Post-Neoadjuvant Therapy
FEATURING
Melinda Telli
- 130 views
- March 7, 2024
- 4
Total Health
Advances in Early Stage TNBC: Treatment Progress
FEATURING
Melinda Telli
- 142 views
- March 7, 2024
- 2
Yale Cancer Center
Reconstruction Options After Breast Cancer
FEATURING
Siba Haykal
- 35 views
- November 25, 2024
Nebraska Oncology Society
Recent Advances in TNBC
FEATURING
Jairam Krishnamurthy
- 138 views
- April 9, 2024
- 1
Yale Cancer Center
Breast Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Therapy
FEATURING
Charles Balch
- 158 views
- April 3, 2024
- 1
ecancer
Highlights From SABCS 2023 Including INAVO120 & NATALEE Trials
FEATURING
Matteo Lambertini
- 323 views
- January 10, 2024
- 1
London Breast Meeting
What's on the Horizon? Breast Reconstruction With Perforator Flaps
FEATURING
Koenraad Van Landuyt
- 91 views
- April 16, 2024
- 1
Yale Cancer Center
Exercise as Standard of Care for Breast Cancer
FEATURING
Melinda Irwin,
Tara Sanft
- 231 views
- February 7, 2024
- 3
Nebraska Oncology Society
ASTRO Guidelines Updates for Partial Breast Irradiation: 4 Key Questions to Consider
FEATURING
Reshma Jagsi
- 114 views
- April 9, 2024
- 2
Yale Cancer Center
Radiation Therapy for Breast Cancer: Basics, Historical Perspectives, and Recent Advances
FEATURING
Meena Moran
- 21 views
- November 25, 2024
ecancer
ESMO 2024 Insights: Neo-CheckRay Trial - Durvalumab & Oleclumab Boost for SBRT + Chemo in ER+/HER2- eBC
FEATURING
Alex De Caluwe
- 29 views
- October 11, 2024
Integrity CE
SABCS 2023 Summary: "Clinical Updates in HER2+ BC"
FEATURING
Paolo Tarantino
- 109 views
- January 24, 2024
Dana-Farber Cancer Institute
Current Treatment Options for Patients With HER2+ mBC
FEATURING
Nancy Lin
- 300 views
- November 14, 2023
- 2
UChicago Medicine
2024 Neoadjuvant IO Updates for HR+ BC
FEATURING
Gini Fleming
- 123 views
- March 1, 2024
- 1
London Breast Meeting
Treatment Options for Elderly and Multimorbid BC Patients
FEATURING
Cornelia Leo
- 65 views
- April 16, 2024
- 3
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Selective RT Omission After Breast-Conserving Surgery
FEATURING
Reshma Jagsi
- 97 views
- April 10, 2024
- 2
OncoAlert
Surgical Oncology Advances in Breast Cancer
FEATURING
Guiseppe Catanuto
- 110 views
- February 15, 2024
- 1
Keck School of Medicine of USC
Sentinel Lymphadenectomy After Neoadjuvant Chemotherapy for Breast Cancer
FEATURING
Terry Mamounas
- 121 views
- February 22, 2024
- 2
Total Health
Current Adjuvant Treatment in BRCA+ BC
FEATURING
Gregory Vidal
- 88 views
- March 12, 2024
- 1
Penn Medicine Abramson Cancer Center
Updates for HR+ BC: Adjuvant CDK4/6i and MRD-Targeted Treatments
FEATURING
Angela DeMichele
- 199 views
- October 23, 2023
- 4
OncoAlert
Breast Cancer Radiation Therapy Updates
FEATURING
Icro Meattini
- 85 views
- February 15, 2024
- 3
Dana-Farber Cancer Institute
What's New in Treatment for TNBC
FEATURING
Megan Tesch
- 152 views
- November 14, 2023
- 4
ecancer
Choosing Wisely for Young Women With Breast Cancer: Radiotherapy
FEATURING
Tabassum Wadasadawala
- 24 views
- October 25, 2024
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Radiation Treatment Considerations
FEATURING
Reshma Jagsi
- 72 views
- April 10, 2024
Sung-Bae Kim
Capitalizing Management of HR+/HER2- mBC: Post-CDK4/6i Therapies in HR+ Disease
- 187 views
- October 13, 2023
- 2
ImmunoTherapy Bridge 2023
Best of SITC 2023 for Clinical Development and IO Trials
FEATURING
Paolo A. Ascierto
- 94 views
- January 11, 2024
- 1
Yale Cancer Center
TNBC Treatment Advances and Clinical Trials
FEATURING
Adriana Kahn
- 96 views
- November 14, 2023
- 3
Total Health
Advances in Early Stage TNBC: IO Progress and Future Direction
FEATURING
Melinda Telli
- 38 views
- March 7, 2024
Keck School of Medicine of USC
Partial Breast Irradiation: Present and Future Treatment Initiatives
FEATURING
Janice Lyons
- 70 views
- February 22, 2024
Dana-Farber Cancer Institute
Recent Advances in mBC and Update on the EMBRACE Program
FEATURING
Nancy Lin
- 96 views
- November 14, 2023
- 1
Nebraska Oncology Society
Axillary Management Considerations After Neoadjuvant Chemotherapy for Breast Cancer
FEATURING
Olga Kantor
- 21 views
- April 10, 2024
Nebraska Oncology Society
2024 Updates in Reconstructive Surgery for Breast Cancer
FEATURING
Marco Maricevich
- 23 views
- April 9, 2024
Yale Cancer Center
Breast Cancer Surgery Updates - Yale School of Medicine
- 79 views
- October 25, 2023
- 1
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Regional Nodal Irradiation
FEATURING
Reshma Jagsi
- 25 views
- April 10, 2024
ecancer
FABREC Study: Effectiveness of Short-Course Radiation vs. Standard Treatment for BC Patients Choosing Reconstruction After Mastectomy
FEATURING
Julia Wong
- 70 views
- October 25, 2023
OncoAlert & Mirrors of Medicine
The Surgeon's View - Multidisciplinary Perspectives in Breast Cancer
- 56 views
- October 13, 2023
NYU Langone
New Frontiers in Breast Reconstruction
FEATURING
Katie Weichman
- 45 views
- November 15, 2023
[PRIVATE] Scripps MD Anderson Cancer Center
The Role of Plastic Surgery in Surgical Oncology: An Evidence-Based Approach
FEATURING
Crystal tenCate
- 38 views
- November 10, 2023
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Contemporary LMD Clinical Trials: Design and Landscape
FEATURING
Priya Kumthekar
- 17 views
- April 30, 2024
Nebraska Oncology Society
Omission of SLNB in Early Stage BC
FEATURING
Olga Kantor
- 15 views
- April 10, 2024
NYU Langone
Navigating a Changing Landscape: New Frontiers in Breast Surgery
FEATURING
Soojin Ahn
- 63 views
- November 15, 2023
Penn Medicine Abramson Cancer Center
Updates for Locoregional Breast Cancer Management: Focus on Radiation for Early BC
FEATURING
Neil Taunk
- 38 views
- October 23, 2023
OncoAlert
Treating Breast Cancer With Limited Resources
FEATURING
Arun Shahi
- 27 views
- February 15, 2024
London Breast Meeting
Lymphedema Preventative Strategies
FEATURING
Ketan Patel
- 16 views
- April 16, 2024
Anna Weiss
Shaping the Future of Breast Cancer Surgery and Treatment: Insights From Clinical Trials
- 19 views
- February 3, 2025
Penn Medicine Abramson Cancer Center
Updates for Locoregional Breast Cancer Management: 52 y/o Post-Menopausal Female
FEATURING
Alina Mateo
- 27 views
- October 23, 2023
Baystate Health
Evolving Strategies in Lymph Node Surgery for Breast Cancer
FEATURING
Holly Mason
- 17 views
- February 3, 2025
Therapeutic Agents
Sara Tolaney
SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer
FEATURING
Hope Rugo
- 1,076 views
- November 19, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-Deruxtecan Related ILD - A Real-World Experience
FEATURING
Kelsey Natsuhara
- 1,356 views
- October 14, 2024
- 6
Kirollos Hanna
Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC
- 2,353 views
- July 19, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EMBER-3 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 458 views
- December 22, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"
FEATURING
Erika Hamilton
- 1,785 views
- June 18, 2024
- 8
Jan-Willem Henning
NATALEE Trial Impact on eBC: Ribociclib + ET as Adjuvant Treatment in Patients With HR+/HER2- Disease
- 618 views
- October 21, 2024
- 7
Miguel Abreu
monarchE Study: The Impact of Dose Reductions on Abemaciclib Efficacy in High-Risk eBC
- 527 views
- September 26, 2024
- 4
Stanford Medicine
Hot Flashes: Nonhormonal Options for Cancer Patients
FEATURING
Milana Dolezal
- 560 views
- September 18, 2024
- 7
Junji Tsurutani
Impact of T-Dxd Approval on HER2-Low mBC Treatment and Patient Outcomes
- 300 views
- November 25, 2024
- 3
Claudine Isaacs
mBC Updates: DESTINY-Breast06 Trial - 1L T-DXd vs. Chemo in HR+ HER2-Low & HER2-Ultralow Disease
- 307 views
- November 4, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EMBER-3 Trial - Imlunestrant Monotherapy and Combined With Abemaciclib in ER+/HER2- aBC
FEATURING
Komal Jhaveri
- 220 views
- January 8, 2025
- 1
Priya Tiwari
Benefits of Oral Formulations in HR+/HER2- mBC: Reducing Time Toxicity and Improving Well-Being
- 529 views
- October 9, 2024
- 2
Insights from ESMO Breast 2024 Annual Meeting
Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Award Lecture
FEATURING
Hope Rugo
- 1,230 views
- June 7, 2024
- 10
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 2,168 views
- April 16, 2024
- 12
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"
FEATURING
Sara Tolaney,
Hope Rugo
- 938 views
- July 4, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: TroFuse-010 Trial - Sacituzumab Tirumotecan ± Pembro vs. Chemo in HR+/HER2- Advanced BC
FEATURING
Sara Tolaney
- 268 views
- November 4, 2024
- 2
Antonio Llombart Cussac
Integrating HER2-Low Targeted Therapies Into the Luminal mBC Treatment Landscape
- 248 views
- November 20, 2024
- 1
Seth Wander
Serial CDK4/6 Inhibitor Therapy for HR+-HER2- MBC: Evolving Insights, Key Questions, and Ongoing Studies
- 573 views
- August 13, 2024
- 5
Integrity CE
Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates
- 272 views
- August 2, 2024
- 2
Integrity CE
SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & Fulvestrant for Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"
FEATURING
Aditya Bardia
- 1,556 views
- January 26, 2024
- 8
Sara Tolaney
ASCO® 2024 Noteworthy Abstracts in Breast Cancer
FEATURING
Hope Rugo
- 936 views
- May 24, 2024
- 10
Rupert Bartsch
Expanding Horizons: HER2-Low mBC and Additional ADC Targets
- 113 views
- January 17, 2025
- 2
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Community Oncologists Highlights"
FEATURING
Sara Tolaney,
Hope Rugo
- 1,189 views
- May 24, 2024
- 11
Yale Cancer Center
Key Trials and Updates in Breast Cancer: Expert Insights
FEATURING
Maryam Lustberg
- 228 views
- October 21, 2024
- 4
Scripps Health
CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC
FEATURING
Sarah Sammons
- 1,756 views
- March 19, 2024
- 10
Scripps Health
Anthracyclines for Early Stage Breast Cancer - Do They Still Have a Role?
FEATURING
Virginia Borges
- 1,364 views
- March 19, 2024
- 18
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Next-Generation SERDs and Their Clinical Applications in ER+ Breast Cancer
FEATURING
Rinath Jeselsohn
- 116 views
- January 14, 2025
- 2
UChicago Medicine
Advances in Targeted and Endocrine Therapies for Metastatic HR+/HER2- Breast Cancer
FEATURING
Nan Chen
- 536 views
- July 11, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: T-DXd in HER2+ mBC With or Without Brain Metastases - DESTINYBreast-12 Primary Results
FEATURING
Nancy Lin
- 224 views
- October 8, 2024
- 1
Christelle Levy
T-DXd for HR+/HER2-Low mBC: Advancing Treatment Options Post-Endocrine Therapy
- 135 views
- December 16, 2024
- 1
Arif Ali Awan
3L Treatment Approaches in HER2+ mBC: Current Gaps and Advancements
- 146 views
- December 20, 2024
- 3
Houston Methodist
Cryoablation - The Big Picture
FEATURING
Davood Abdollahian
- 146 views
- October 14, 2024
Cleveland Clinic Taussig Cancer Institute
Endocrine Therapy in Young Women With Early BC
FEATURING
Erin Roesch
- 263 views
- September 6, 2024
- 4
Dana-Farber Cancer Institute
What's New in Breast Cancer?
FEATURING
Sara Tolaney
- 1,560 views
- January 17, 2024
- 15
Avan Armaghani
ASCO® 2024 Review: Treatment Updates on TNBC and HR+/HER2- Breast Cancer
- 285 views
- August 9, 2024
- 2
Patrick Neven
Patient Selection for Adjuvant Abemaciclib in HR+/HER2- eBC
- 229 views
- September 19, 2024
- 1
Houston Methodist
Cryoablation for Breast Cancer: The Basics
FEATURING
Luz Venta
- 138 views
- October 8, 2024
- 1
University of Illinois Cancer Center
ADC Therapy for Metastatic HR+/HER2- BC
FEATURING
V.K. Gadi
- 85 views
- December 6, 2024
- 2
University of Illinois Cancer Center
Metastatic HR+/HER2- BC: CDK4/6 Inhibitor Insights and Next-Line Treatment Options
FEATURING
V.K. Gadi
- 107 views
- December 6, 2024
Adrienne Waks
New Insights Into Optimizing HER2-Directed Therapy in the Curative Setting
- 231 views
- August 13, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Pembro or Placebo + CT in High-Risk Early TNBC - OS Results From KEYNOTE-522
FEATURING
Heather McArthur
- 158 views
- September 24, 2024
- 3
University of Illinois Cancer Center
Key Updates and Insights on HER2+ Breast Cancer
FEATURING
V.K. Gadi
- 197 views
- August 20, 2024
- 1
Stanford Medicine
HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sensitivity
FEATURING
Milana Dolezal
- 1,055 views
- February 27, 2024
- 7
Katarzyna Jerzak
Advancements in Treatment Strategies for HR+/HER2- mBC: Current and Future Perspectives
- 197 views
- August 29, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: neoHIP Study of Neoadjuvant HER2-Targeted Therapy +/- IO With Pembrolizumab
FEATURING
Heather McArthur
- 58 views
- January 2, 2025
- 2
Insights from 2023 SABCS
SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuvant eBC Setting?"
FEATURING
Sara Tolaney,
Hope Rugo
- 1,524 views
- December 21, 2023
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Adjuvant Ribociclib + NSAI in HR+/HER2- eBC - 4-Year Outcomes From the NATALEE Trial
FEATURING
Peter Fasching
- 91 views
- November 19, 2024
- 1
Keck School of Medicine of USC
CDK4/6 Inhibitors in Breast Cancer: 2024 Update
FEATURING
Ruth O'Regan
- 917 views
- February 22, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CAPItello-290 Trial - Capivasertib + Paclitaxel as 1L Treatment for mTNBC
FEATURING
Heather McArthur
- 144 views
- September 24, 2024
- 1
Cleveland Clinic Taussig Cancer Institute
Bone Health in Premenopausal Women With Early BC Receiving ET
FEATURING
Sabashini Ramchand
- 165 views
- September 6, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 551 views
- July 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO 2024 Highlights: Insights From Key Abstracts on mBC
FEATURING
Sramila Aithal
- 206 views
- August 27, 2024
- 2
Jan-Willem Henning
monarchE Trial & High-Risk eBC: Efficacy, Safety, QoL, and Biomarker Analysis
- 139 views
- October 22, 2024
OncoPharm
Managing Inavolisib-Related Stomatitis in HR+/HER2- mBC: Dexamethasone Mouthwash Approach
FEATURING
John Bossaer
- 58 views
- January 21, 2025
UChicago Medicine
Antibody Drug Conjugates: Overview and Background of a Revolution in Breast Cancer Treatment
FEATURING
Hope Rugo
- 545 views
- March 4, 2024
- 4
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 2L Setting
FEATURING
Ruth O'Regan
- 466 views
- March 12, 2024
- 2
Oncology Data Advisor
ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan for 2L & Later Treatment of mTNBC"
FEATURING
Kevin Kalinsky
- 1,045 views
- November 7, 2023
- 2
Stanford Medicine
Sexual Health and Wellbeing in Women’s Cancer Survivors
FEATURING
Milana Dolezal
- 223 views
- July 10, 2024
- 4
University of Colorado Cancer Center
Optimal Treatment for Early Stage HER2+ BC: Tailoring Treatment to Response
FEATURING
Virginia Borges
- 354 views
- May 1, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA Trial - CDK4/6 Inhibitors in Maintenance Therapy for HER2+ mBC
FEATURING
Erika Hamilton
- 42 views
- January 7, 2025
Stanford Medicine
HR+ mBC: CDK4/6i Progression Management
FEATURING
Milana Dolezal
- 723 views
- February 27, 2024
- 4
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Breast Cancer Brain Metastases: From a Medical Oncologist’s Perspective
FEATURING
Rebecca Dent
- 352 views
- April 30, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: PROMENADE Trial - Pembro for Early ER-Low/HER2- BC - Real World French Cohort
FEATURING
Francois Cherifi
- 94 views
- September 23, 2024
- 2
University of Illinois Cancer Center
Clinical Guidance on the Management and Monitoring of T-DXd-Related Adverse Events in HER2+ mBC
FEATURING
V.K. Gadi
- 325 views
- May 28, 2024
- 4
Cedars Sinai
Unmet Need in HR+/HER2- mBC: Resistance to 1L CDK4/6i and ET
FEATURING
Yuan Yuan
- 426 views
- April 18, 2024
- 2
Miami Cancer Institute Precision Oncology Symposium
HER2 Targeted Treatments in Lower BC Expression Ranges
FEATURING
Ian Krop
- 228 views
- July 2, 2024
- 2
Robert Wesolowski
Clinical Implications of the EMERALD Data on Treatment Outcomes in HR+/HER2- mBC
- 736 views
- February 29, 2024
- 3
ecancer
ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"
FEATURING
Jane Meisel
- 240 views
- June 20, 2024
UChicago Medicine
New and Emerging CDK4/6i Therapies for Advanced HR+ BC
FEATURING
Nan Chen
- 346 views
- March 4, 2024
- 6
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Frontiers in Breast Cancer Brain Metastasis: ADC Effectiveness in the CNS
FEATURING
Shanu Modi
- 295 views
- April 30, 2024
- 3
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"
FEATURING
Sara Tolaney,
Hope Rugo
- 1,083 views
- November 3, 2023
- 10
Cleveland Clinic Taussig Cancer Institute
Targetable Mutations in HR+/HER2- mBC
FEATURING
Megan Kruse
- 679 views
- January 24, 2024
- 4
Total Health
Systemic Therapy for HER2+ CNS Disease: Management of Breast Cancer Brain Mets
FEATURING
Cesar Santa-Maria
- 484 views
- February 29, 2024
- 1
Mattea Reinisch
Real-World Management of Patients With mTNBC Receiving Sacituzumab Govitecan
- 227 views
- July 4, 2024
Scripps Health
2024 Neuro-Oncology Update: Breast Cancer and Brain Mets
FEATURING
Tresa McGranahan
- 375 views
- April 2, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: IBI354 - Anti-HER2 ADC in Advanced Solid Tumors and Breast Cancer
FEATURING
Christina Teng
- 82 views
- October 1, 2024
- 2
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Chemoprevention in Brain Mets: Breast Cancer Perspective
FEATURING
Alexandra Zimmer
- 289 views
- April 30, 2024
- 7
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for HER2+, High-Risk, Early Stage BC
FEATURING
Rita Nanda
- 351 views
- March 1, 2024
- 2
Total Health
Management of Endocrine Therapy Toxicity in Breast Cancer
FEATURING
Naomi Dempsey
- 454 views
- February 28, 2024
- 4
ecancer
KEYNOTE-756 Trial - Adding Pembro to Chemo Before and After BC Surgery
FEATURING
Javier Cortes
- 345 views
- April 23, 2024
- 2
Total Health
Antibody Drug Conjugates: Highlights in Breast Cancer
FEATURING
Kevin Kalinsky
- 341 views
- March 12, 2024
- 1
Miami Cancer Institute Precision Oncology Symposium
Incorporating IO and Emerging Therapeutic Strategies for mTNBC
FEATURING
Reshma L. Mahtani
- 156 views
- July 2, 2024
ecancer
ESMO 2024 Insights: WSG-TP-II Trial - ET + Trastuzumab & Pertuzumab vs. De-Escalated Chemo + Trastuzumab & Pertuzumab in HR+/HER2+ eBC
FEATURING
Oleg Gluz
- 49 views
- October 11, 2024
- 1
Oncology Data Advisor
Highlights of the 2023 SABCS: HER2CLIMB-02, MONARCH3, and INAVO120 Trials
FEATURING
Jason Mouabbi
- 201 views
- January 26, 2024
Dana-Farber Cancer Institute
Antibody Drug Conjugates Highlights - mBC Series
FEATURING
Harold Burstein
- 329 views
- February 15, 2024
- 5
Keck School of Medicine of USC
2024 Updates on the Future of ADCs in Breast Cancer
FEATURING
Charles Geyer
- 368 views
- February 22, 2024
- 2
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC
FEATURING
Rita Nanda
- 262 views
- March 1, 2024
- 5
Total Health
Immune Checkpoint Inhibitors and Neoadjuvant Chemo for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 238 views
- March 2, 2024
Insights from 2023 SABCS
SABCS 2023 Insights: "The Future of Oral SERDs in Breast Cancer"
FEATURING
Erika Hamilton
- 439 views
- December 19, 2023
- 4
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in mBC
FEATURING
Sudha Yarlagadda
- 88 views
- August 27, 2024
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Successes and Challenges of Early Drug Development for Brain Metastasis
FEATURING
Alex Drilon
- 310 views
- April 30, 2024
- 2
Insights from 2023 SABCS
SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for Patients With HR+ mBC With Early Relapse and a PI3Km?"
FEATURING
Sara Tolaney,
Hope Rugo
- 478 views
- December 21, 2023
- 2
Integrity CE
TROP-2 ADCs for the Treatment of HR+/HER2- BC, TNBC, and NSCLC: Advancing Care in the Community Oncology Setting
FEATURING
Lee Schwartzberg,
Jason Porter
- 125 views
- March 20, 2024
- 1
Stanford Medicine
ADCs in HR+ Advanced/Metastatic BC
FEATURING
Milana Dolezal
- 299 views
- February 27, 2024
- 4
Yale Cancer Center
Innovations in Breast Medical Oncology: Immunotherapy in eBC
FEATURING
Kathleen Fenn
- 38 views
- November 13, 2024
Cedars Sinai
Management of Toxicities Associated With Targeted Agents in Stage 4 HR+/HER2- BC
FEATURING
Yuan Yuan
- 280 views
- April 18, 2024
- 2
Total Health
ADCs in Breast Cancer: Datopotamab Deruxtecan Overview
FEATURING
Heather McArthur
- 178 views
- March 12, 2024
- 3
Insights from 2023 SABCS
SABCS 2023 Insights: "The Role for Dato-DXd in HR+ mBC"
FEATURING
Sara Tolaney,
Hope Rugo
- 404 views
- January 22, 2024
- 2
Total Health
Current Adjuvant Treatment in HER2+ BC
FEATURING
Gregory Vidal
- 255 views
- March 12, 2024
- 1
Insights from 2023 ESMO Annual Meeting
Systemic Therapy of CNS Disease in HER2+ BC
FEATURING
Soo Chin Lee
- 308 views
- February 15, 2024
- 1
UChicago Medicine
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CAm Tumors, Capivasertib for AKT Pathway-Altered Tumors
FEATURING
Nan Chen
- 228 views
- March 4, 2024
- 1
ecancer
ESMO 2023 Insights: "Phase 3 TROPION-Breast01 Trial - Datopotamab Deruxtecan Compared to Chemo in Patients With Advanced HR+/HER2- BC"
FEATURING
Aditya Bardia
- 604 views
- October 27, 2023
- 5
Dana-Farber Cancer Institute
Antibody Drug Conjugates in Breast Cancer
FEATURING
Sara Tolaney
- 455 views
- November 14, 2023
- 6
Total Health
Antibody Drug Conjugates: Future Applications in Breast Cancer
FEATURING
Kevin Kalinsky
- 238 views
- March 12, 2024
- 3
Yale Cancer Center
Updates on Metastatic Breast Cancer - Yale Cancer Center
FEATURING
Daniel O'Neil
- 566 views
- November 10, 2023
- 3
Yale Cancer Center
Identifying and Targeting DNA Repair Mutations in Cancer
FEATURING
Shridar Ganesan
- 39 views
- October 14, 2024
UChicago Medicine
2024 Updates on ADCs in HER2-Low, HR+, and TNBC
FEATURING
Hope Rugo
- 204 views
- March 4, 2024
- 3
Integrity CE
SABCS 2023 Insights: "TROPION-Breast01 - Dato-DXd Compared to Chemo in Advanced HR+/HER2- BC"
FEATURING
Aditya Bardia
- 180 views
- January 26, 2024
- 1
Total Health
The Role of Radiation Therapy in Oncology
FEATURING
Ryan Lanning
- 119 views
- July 1, 2024
Insights from 2023 SABCS
SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatinib & Trastuzumab Emtansine for Previously Treated HER2+ mBC"
FEATURING
Sara A. Hurvitz
- 352 views
- December 12, 2023
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd
FEATURING
Sara Tolaney
- 17 views
- December 17, 2024
Total Health
ADCs in Breast Cancer: Sacituzumab Govitecan Overview
FEATURING
Heather McArthur
- 147 views
- March 12, 2024
- 1
OncoAlert
Newer Developments in Advanced HR+/HER2- BC
FEATURING
Erika Hamilton
- 199 views
- February 15, 2024
- 2
Nebraska Oncology Society
2024 Updates in mTNBC
FEATURING
Jairam Krishnamurthy
- 126 views
- April 10, 2024
- 1
Insights from 2023 SABCS
SABCS 2023 Insights: "Sequential Use of ADCs T-DXd & SG in Patients With HER2-Low mBC"
FEATURING
Laura Huppert
- 218 views
- December 20, 2023
- 2
NYU Langone
ADCs in Breast Cancer: Promises and Limitations
FEATURING
Paolo Tarantino
- 332 views
- November 15, 2023
- 6
OncoPharm
Inavolisib Approval: Advancing Treatment for HR+/HER2- mBC With PI3K Inhibitors
FEATURING
John Bossaer
- 21 views
- January 21, 2025
- 1
Dana-Farber Cancer Institute
ER+ Disease Highlights - mBC Series
FEATURING
Harold Burstein
- 145 views
- February 15, 2024
- 1
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Rapid Insights"
FEATURING
Sara Tolaney,
Hope Rugo
- 60 views
- May 28, 2024
Nebraska Oncology Society
Early Stage TNBC Updates
FEATURING
Jairam Krishnamurthy
- 106 views
- April 9, 2024
- 1
2023 Evolution Conference
New Frontiers in Triple Negative Breast Cancer
FEATURING
Reshma L. Mahtani
- 303 views
- November 8, 2023
- 5
Cleveland Clinic Taussig Cancer Institute
Options for Breast Neurotization: How I Do It
FEATURING
Ziv Peled
- 45 views
- September 3, 2024
ecancer
ASH 2024 Insights: Incidence of Thrombosis With Breast Cancer Targeted Therapies
FEATURING
James Martin
- 18 views
- January 17, 2025
West Cancer Center
Patient Selection for CDK4/6i in HR+/HER2- Advanced BC
FEATURING
Gregory Vidal
- 262 views
- November 27, 2023
- 2
Penn Medicine Abramson Cancer Center
mTNBC: Which ADC and When?
FEATURING
Payal Shah
- 296 views
- October 23, 2023
- 1
ecancer
HER2CLIMB-02 Trial - T-DM1 + Tucatinib in Patients With Unresectable Locally Advanced or Metastatic HER2+ BC
FEATURING
Sara A. Hurvitz
- 194 views
- January 24, 2024
Total Health
Systemic Therapy for HER2- CNS Disease: Management of Breast Cancer Brain Mets
FEATURING
Cesar Santa-Maria
- 81 views
- February 29, 2024
UChicago Medicine
Advanced ER+ BC: Novel Endocrine Agents Such as ER PROTACs and ER CERANs With Promising Early Phase Data
FEATURING
Nan Chen
- 106 views
- March 4, 2024
- 2
Yale Cancer Center
Radiation Therapy in Breast Cancer Treatment
FEATURING
Susan Higgins
- 22 views
- November 25, 2024
Houston Methodist
Cryoablation: Abscopal Effect and Immune Therapy
FEATURING
Robert Ward
- 171 views
- October 17, 2023
- 1
Houston Methodist
Cryoablation: Abscopal Effect & Immune Therapy
FEATURING
Robert Ward
- 16 views
- October 14, 2024
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or Alpelisib, in ER+/HER2- Advanced BC"
FEATURING
Komal Jhaveri
- 159 views
- December 1, 2023
- 2
ecancer
SABCS 2023 Insights: "Zanidatamab, Palbociclib, and Fulvestrant in HER2+/HR+ mBC"
FEATURING
Santiago Escrivá
- 125 views
- January 10, 2024
- 4
London Breast Meeting
IO in Breast Cancer: Harnessing the Power of the Immune System
FEATURING
Alicia Okines
- 43 views
- April 16, 2024
Insights from 2023 SABCS
SABCS 2023 Insights: "ELEVATE Study Evaluating Elacestrant in Various Combinations in Patients With ER+, HER2- Locally Advanced or mBC"
FEATURING
Hope Rugo
- 148 views
- December 15, 2023
- 1
Houston Methodist
Early Interception in Breast Cancer: Organ Preservation and Avoidance of Systemic Side Effect
FEATURING
Pamela Munster
- 21 views
- September 18, 2024
Dana-Farber Cancer Institute
What’s New in Research for ER+ mBC
FEATURING
Antonio Giordano
- 148 views
- November 14, 2023
- 6
Laurence Buisseret
Clinical Overview of IO Development in HER2+ BC and Future Directions
- 136 views
- February 8, 2024
Houston Methodist
Integrating Cryoablation and Breast Cancer Treatment
FEATURING
Jenny Chang
- 151 views
- October 17, 2023
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "H3B-6545 in Women With ER+/HER2- mBC"
FEATURING
Erika Hamilton
- 31 views
- June 18, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ACE-Breast-02 Trial - ARX788 vs. Lapatinib + Capecitabine in HER2+ ABC"
FEATURING
Xi-Chun Hu
- 52 views
- June 12, 2024
- 1
London Breast Meeting
How to Avoid Implant Lateralization and Casualization in an Unstable Implant
FEATURING
Charles Randquist
- 53 views
- April 16, 2024
Dana-Farber Cancer Institute
HER2+ mBC: What’s Coming Up in Research?
FEATURING
Adrienne Waks
- 114 views
- November 14, 2023
- 1
Houston Methodist
Evolution of Ablation for Malignant Tumors: The Big Picture
FEATURING
Davood Abdollahian
- 183 views
- October 17, 2023
- 1
London Breast Meeting
How to Avoid Lower Pole Stretch
FEATURING
Patrick Mallucci
- 32 views
- April 16, 2024
Patrick Neven
Management of Toxicities Associated With Targeted Agents in HR+/HER2- mBC
- 110 views
- January 3, 2024
- 1
Insights from 2023 SABCS
SABCS 2023 Insights: "CDK4/6 Inhibition as a Potential Vulnerability in NF1-Depleted ER+ Breast Cancer"
FEATURING
Eric Chang
- 98 views
- January 3, 2024
- 2
Roberto Leon Ferre
Clinical Scenarios in mTNBC: Treatment Approaches in 2L
- 141 views
- November 3, 2023
- 1
Ciara O'Sullivan
HER2+ Metastatic Breast Cancer: Overview of HER2CLIMB Trial
- 25 views
- February 3, 2025
OncoAlert
Updates in Targeted Therapies for Solid Tumors
FEATURING
Benedikt Westphalen
- 66 views
- February 17, 2024
UChicago Medicine
ADCs in Breast Cancer: Ongoing Trials and Future Directions
FEATURING
Hope Rugo
- 53 views
- March 4, 2024
Houston Methodist
Cryoablation of Breast Carcinoma: Pathologic Findings
FEATURING
Mary Schwartz
- 123 views
- October 17, 2023
- 2
Penn Medicine Abramson Cancer Center
Updates in HER2+ mBC: 47 y/o Female With Multiple Brain Mets
FEATURING
Meher Burki
- 133 views
- October 22, 2023
Dana-Farber Cancer Institute
What's New in Research for mTNBC
FEATURING
Paolo Tarantino
- 124 views
- November 14, 2023
- 1
ecancer
SABCS 2023 Insights: "ALEXANDRA/IMpassion030 Trial - Adding Atezo to Adjuvant Chemo for Stage II & III TNBC"
FEATURING
Michail Ignatiadis
- 76 views
- January 24, 2024
- 1
Erika Hamilton
Vepdegestrant, a PROTAC ER Degrader, in ER+/HER2- Advanced BC: Update of Dose Escalation Results
- 60 views
- November 3, 2023
- 1
Sung-Bae Kim
What Breast Cancer Doctors Want to Know About How to Detect and Manage Toxicity From Immunotherapy
- 99 views
- October 13, 2023
- 1
University of Colorado Cancer Center
Type 2 Diabetes Risk With Endocrine Therapies for Breast Cancer
FEATURING
Rebecca Scalzo
- 22 views
- May 9, 2024
Yale Cancer Center
Recent Advances & Ongoing Trials in HER2+ BC
FEATURING
Daniel O'Neil
- 85 views
- November 14, 2023
Houston Methodist
Post Cryoablation Pathological Findings
FEATURING
Mary Schwartz
- 7 views
- October 8, 2024
ecancer
SABCS 2023 Insights: "Toripalimab + Metronomic Chemo in Treating in HER2- mBC"
FEATURING
Hongnan Mo
- 36 views
- January 10, 2024
- 1
ecancer
The Latest Special Issue of Medical Science on the Use of Real-World Data in Global Breast Cancer Management
FEATURING
Siddhartha Kar
- 50 views
- December 10, 2023
- 1
Total Health
ADCs in Breast Cancer: Trastuzumab Emtansine Overview
FEATURING
Heather McArthur
- 28 views
- March 12, 2024
Masonic Cancer Center, University of Minnesota
Lobular Carcinoma of the Breast: MDC1 & Gene Regulations
FEATURING
Matthew Sikora
- 14 views
- March 15, 2024
University of Louisville
Role of m6A in RNA Transcripts in Endocrine-Therapy Resistance in Breast Cancer Cells
FEATURING
Carolyn Klinge
- 13 views
- March 12, 2024
Diagnostics & Biomarkers
Shabnam Jaffer
The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: Best Practices
- 1,026 views
- September 23, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in mBC
FEATURING
Giampaolo Bianchini
- 731 views
- October 1, 2024
- 8
Fernanda Mosele
Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in mBC: Key Results From the DAISY Trial
- 576 views
- October 16, 2024
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Precision Medicine in Breast Cancer
FEATURING
Laura van ’t Veer
- 362 views
- December 19, 2024
Adam Brufsky
Brief Update on Genomic Assays for Early Stage Breast Cancer
- 487 views
- September 11, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With Trastuzumab Deruxtecan in mBC
FEATURING
Paolo Tarantino
- 366 views
- October 1, 2024
- 5
ecancer
SABCS 2024 Summary: Highlights in Breast Cancer Genomic Testing - A Guide to Precision Treatment
FEATURING
Matteo Lambertini,
Virginia Kaklamani
- 210 views
- January 17, 2025
Sherry Yang
TAILORx Trial: Endocrine Therapy, 21-Gene Recurrence Score, and Clinical Outcomes in eBC
- 236 views
- November 20, 2024
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: MammaPrint® and Predictive Pathways of CDK4/6 Inhibitor Resistance in ER+/HER2- eBC
FEATURING
Adam Brufsky
- 144 views
- December 20, 2024
- 3
COR2ED The Heart of Medical Education
The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC
FEATURING
Umberto Malapelle
- 301 views
- October 1, 2024
- 3
Rani Bansal
Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer: Insights From a Large Molecular Profiling Study
- 160 views
- December 23, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Prediction of Chemotherapy Benefit by MammaPrint® in HR+/HER2- eBC - FLEX Registry Data
FEATURING
Adam Brufsky
- 146 views
- December 20, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Development and Validation of RSClinN+ Tool for HR+/HER2- Node-Positive BC
FEATURING
Lajos Pusztai
- 846 views
- June 17, 2024
- 5
Nathalie Johnson
High Risk HR+ BC: Optimizing Systemic Chemo With Genomic Testing
- 94 views
- January 27, 2025
- 5
Springer Healthcare IME
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics
FEATURING
Solange Peters
- 200 views
- October 29, 2024
- 5
Miami Cancer Institute Precision Oncology Symposium
Precision Therapy for HR+/HER2- mBC
FEATURING
Joyce O'Shaughnessy
- 533 views
- July 2, 2024
- 7
Han-Byoel Lee
Identifying Breast Cancer Subtypes and Recurrence Risk: Multigene Assays in Treatment Decisions
- 337 views
- August 27, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: ctDNA and Molecular Screening for Target Detection and Treatment Monitoring in mBC
FEATURING
Michail Ignatiadis
- 173 views
- September 26, 2024
Cleveland Clinic Taussig Cancer Institute
Breast Imaging and the Young Patient
FEATURING
Laura Dean
- 242 views
- September 3, 2024
- 7
Yale Cancer Center
HER2 Ultra-Low: Is It Real? A Close Look at Companion Diagnostics for Trastuzumab Deruxtecan (T-DXd) in Breast Cancer
FEATURING
David Rimm
- 133 views
- October 25, 2024
Fabian Kiessling
Molecular and Superresolution Ultrasound Imaging to Characterize Breast Cancer
- 101 views
- January 17, 2025
- 1
Insights from 2023 SABCS
SABCS 2023 Insights: "ctDNA Monitoring of ER+/HER2- High Risk Breast Cancer During Adjuvant Endocrine Therapy"
FEATURING
Lajos Pusztai
- 1,630 views
- January 2, 2024
- 9
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in Early Stage BC
FEATURING
Frederick Howard
- 240 views
- August 26, 2024
Fred Hutchinson Cancer Center
Biology and Clinical Relevance of ESR1 Mutation in Breast Cancer
FEATURING
Nancy Davidson
- 259 views
- August 2, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Long-Term Outcomes and Treatment Strategies by ER Expression in Breast Cancer
FEATURING
Kazuki Nozawa
- 124 views
- October 29, 2024
- 1
Weill Cornell Medicine Oncology & Hematology
Inflammatory Breast Cancer - Diagnosis and Management Updates
FEATURING
Massimo Cristofanilli
- 507 views
- May 15, 2024
- 4
Aurelio Castrellon
Prognostic Roles of AMH and ctDNA Detection in HR+/HER2- Node+ eBC
- 220 views
- August 20, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Elucidating the Immune Active State of HR+/HER2- MammaPrint High 2 Early BC"
FEATURING
Erin Cobain
- 366 views
- June 18, 2024
- 3
Cleveland Clinic Taussig Cancer Institute
Genomic Landscape of Young and Older Onset Breast Cancer
FEATURING
Shimoli Barot
- 123 views
- September 11, 2024
University of Colorado Cancer Center
Young Women With HR+/HER2- Breast Cancer: Options for Risk Assessment
FEATURING
Virginia Borges
- 438 views
- May 1, 2024
- 3
Alessia Pellerino
Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addressing Unmet Needs
- 172 views
- August 29, 2024
- 2
Weill Cornell Medicine Oncology & Hematology
Defining High-Risk HR+/HER2- eBC: Clinical Pearls for Oncologists
FEATURING
Eleonora Nicolò
- 184 views
- August 22, 2024
- 1
UNC Lineberger Comprehensive Cancer Center
The Importance of Molecular Testing in HR+/HER2- mBC
FEATURING
Yara Abdou
- 383 views
- April 2, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemo in Young Patients With eBC
FEATURING
Megan Tesch
- 77 views
- December 17, 2024
- 2
Houston Methodist
Novel Approaches in Oncology: Early Interception & BRCA Advances in Breast & Ovarian Cancer Therapy
FEATURING
Pamela Munster
- 34 views
- September 18, 2024
Rupert Bartsch
Antibody-Drug Conjugates and Predictive Biomarkers in mTNBC and HR+/HER2- mBC
- 38 views
- January 17, 2025
COR2ED The Heart of Medical Education
Treating ER+/HER2-Low mBC: 2L and Beyond
FEATURING
Aditya Bardia
- 258 views
- June 4, 2024
- 5
Lajos Pusztai
Evaluating PCR as an Endpoint for Approving New Therapies in eBC
- 167 views
- August 9, 2024
- 2
University of Illinois Cancer Center
The Role of ctDNA as a Surveillance Approach in HR+/HER2- eBC
FEATURING
V.K. Gadi
- 1,153 views
- November 15, 2023
- 7
UChicago Medicine
Racial Disparities in Breast Cancer Screening and Diagnosis
FEATURING
Nan Chen
- 117 views
- August 29, 2024
Houston Methodist
BRCA2 Mutations and Hereditary Cancer Risk
FEATURING
Pamela Munster
- 67 views
- September 18, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Breast Cancer Polygenic Risk Score and Patient Survival Outcomes in Pathways Study
FEATURING
Arya Mariam Roy
- 56 views
- December 19, 2024
Jennifer Sass
US EPA Evaluation of Endocrine Disrupting Chemicals (EDCs)
- 717 views
- October 9, 2023
- 3
Keck School of Medicine of USC
Estrogen Receptor-Targeted PET Imaging: Clinical Applications and Interpretation
FEATURING
Gary Ulaner
- 371 views
- February 22, 2024
- 5
Total Health
Genetic Testing and Management of Breast Cancer Susceptibility - Germline Mutations
FEATURING
Claudine Isaacs
- 150 views
- February 29, 2024
- 1
Everardo Saad
Surrogate Endpoints: Demystifying Their Role in Breast Cancer Research
- 46 views
- December 2, 2024
Cleveland Clinic Taussig Cancer Institute
Counseling Women With a Genetic Predisposition to Breast Cancer
FEATURING
Claudine Isaacs
- 51 views
- September 3, 2024
Oncology Data Advisor
AI Advancing Breast Cancer Detection: Insights From iCAD
FEATURING
Waqas Haque,
Dana Brown
- 19 views
- September 18, 2024
ecancer
ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact of Genetic Testing in Young BRCA Breast Cancer Patients"
FEATURING
Matteo Lambertini
- 84 views
- July 2, 2024
- 1
Insights from 2023 SABCS
SABCS 2023 Insights: "Innovative Approaches at the Diagnosis and Treatment of Invasive Lobular Carcinoma"
FEATURING
Jason Mouabbi
- 258 views
- January 3, 2024
- 2
Total Health
Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclines & HER2
FEATURING
Isaac Rhea
- 110 views
- March 6, 2024
- 1
Yale Cancer Center
Evaluating the Effectiveness of New Technologies in Breast Cancer Screening
FEATURING
Ilana Richman
- 45 views
- October 1, 2024
UChicago Medicine 12th International Clinical Cancer Genomics Conference
The Promise of Multi-Cancer Detection Assays
FEATURING
Peter Kuhn
- 110 views
- May 21, 2024
- 2